Department of Dermatology, Venereology and Allergology, Ruhr-University, Bochum, Germany.
Department of Dermatology, Monklands Hospital, Lanarkshire, UK.
J Eur Acad Dermatol Venereol. 2018 May;32(5):752-756. doi: 10.1111/jdv.14682. Epub 2017 Dec 18.
Actinic keratoses (AKs) are commonly diagnosed clinically. Actinic keratosis area and severity index (AKASI) is a new easy-to-use tool to assess the severity of AKs on the head.
To determine the association between chronically UV-induced tumours such as basal cell carcinomas (BCC) or squamous cell carcinomas (SCC) and AKASI.
We performed a retrospective analysis of patients who had undergone oncological surgery due to UV-induced tumours and who were assessed for AKASI and Physician's global assessment (PGA) prior to surgery. Statistical analysis was performed to evaluate correlation between AKASI, PGA and invasive carcinomas.
Of the 210 patients included, 26 patients had histologically diagnosed SCCs and presented with a median (range) AKASI of 6.9 (0-13.0) and PGA of 2 (0-4). In contrast, the 82 patients with BCCs showed a median (range) AKASI of 3.3 (0-15.2) and PGA of 1 (0-4). The Mann-Whitney U-test showed significant differences (P = 0.0018) between AKASI of patients with SCC and BCC. In addition, we found a significantly higher AKASI in patients with SCC compared to patients with non-invasive lesions like AK and Bowen disease (BD) (P = 0.0275). Spearman's coefficient of rank correlation between AKASI and PGA indicates that these measures of AK severity were strongly correlated (P < 0.0001; r = 0.90; 95% CI 0.865-0.920).
Patients with SCC show significantly higher AKASI than patients with BCC or patients without invasive tumours. Hence, AKASI may be used to stratify risk for developing invasive SCC.
光化性角化病(AK)通常通过临床诊断。光化性角化病面积和严重指数(AKASI)是一种新的用于评估头部 AK 严重程度的简单易用的工具。
确定慢性紫外线诱导肿瘤(如基底细胞癌(BCC)或鳞状细胞癌(SCC))与 AKASI 之间的关联。
我们对因紫外线诱导肿瘤而接受肿瘤手术的患者进行了回顾性分析,并在手术前评估了 AKASI 和医生整体评估(PGA)。进行了统计分析,以评估 AKASI、PGA 和浸润性癌之间的相关性。
在 210 例患者中,26 例患者组织学诊断为 SCC,中位(范围)AKASI 为 6.9(0-13.0)和 PGA 为 2(0-4)。相比之下,82 例 BCC 患者的中位(范围)AKASI 为 3.3(0-15.2)和 PGA 为 1(0-4)。Mann-Whitney U 检验显示 SCC 和 BCC 患者的 AKASI 存在显著差异(P=0.0018)。此外,我们发现 SCC 患者的 AKASI 明显高于 AK 和 Bowen 病(BD)等非浸润性病变患者(P=0.0275)。AKASI 和 PGA 之间的 Spearman 秩相关系数表明,这些 AK 严重程度的测量值具有很强的相关性(P<0.0001;r=0.90;95%置信区间 0.865-0.920)。
SCC 患者的 AKASI 明显高于 BCC 或无浸润性肿瘤患者。因此,AKASI 可用于分层 SCC 浸润的风险。